These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10534250)

  • 61. L-dopa effects on preprogramming and control activity in a skilled motor act in Parkinson's disease.
    Fattapposta F; Pierelli F; My F; Mostarda M; Del Monte S; Parisi L; Serrao M; Morocutti A; Amabile G
    Clin Neurophysiol; 2002 Feb; 113(2):243-53. PubMed ID: 11856629
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of drug manipulations on anterior components of somatosensory evoked potentials in a parkinsonian animal model.
    Onofrj M; Ferracci F; Fulgente T; Malatesta G; Ghilardi MF
    Drugs Exp Clin Res; 1994; 20(1):29-36. PubMed ID: 7924892
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Absence of relationships between L-dopa plasma levels and therapeutic effect in Parkinson's disease treated with L-dopa.
    Algeri S; Ruggieri S; Miranda F; Casacchia M; Morselli PL; Agnoli A
    Eur Neurol; 1976; 14(3):219-28. PubMed ID: 1278194
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Median nerve somatosensory evoked potentials and their high-frequency oscillations in amyotrophic lateral sclerosis.
    Hamada M; Hanajima R; Terao Y; Sato F; Okano T; Yuasa K; Furubayashi T; Okabe S; Arai N; Ugawa Y
    Clin Neurophysiol; 2007 Apr; 118(4):877-86. PubMed ID: 17307389
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Frontal distribution of early cortical somatosensory evoked potentials to median nerve stimulation.
    Tsuji S; Murai Y; Hashimoto M
    Electroencephalogr Clin Neurophysiol; 1988; 71(4):273-9. PubMed ID: 2454792
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Retrograde effects of digital nerve severance on somatosensory evoked potentials in man.
    Chu NS
    Muscle Nerve; 1994 Mar; 17(3):313-9. PubMed ID: 8107708
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A prospective one-year follow-up study with somatosensory potentials evoked by stimulation of the median nerve in patients with cerebral infarct.
    Kovala T; Tolonen U; Pyhtinen J
    Electromyogr Clin Neurophysiol; 1993 Sep; 33(6):359-67. PubMed ID: 8223336
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neuroplastic changes related to pain occur at multiple levels of the human somatosensory system: A somatosensory-evoked potentials study in patients with cervical radicular pain.
    Tinazzi M; Fiaschi A; Rosso T; Faccioli F; Grosslercher J; Aglioti SM
    J Neurosci; 2000 Dec; 20(24):9277-83. PubMed ID: 11125006
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Short-latency somatosensory evoked potentials in dystrophia myotonica.
    Bartel PR; Lotz BP; Van der Meyden CH
    J Neurol Neurosurg Psychiatry; 1984 May; 47(5):524-9. PubMed ID: 6736985
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Low- and high-frequency subcortical SEP amplitude reduction during pure passive movement.
    Insola A; Padua L; Mazzone P; Valeriani M
    Clin Neurophysiol; 2015 Dec; 126(12):2366-75. PubMed ID: 25953142
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Episodic unresponsiveness to single doses of L-dopa in parkinsonian fluctuators.
    Melamed E; Bitton V; Zelig O
    Neurology; 1986 Jan; 36(1):100-3. PubMed ID: 3941762
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of cervical spinal cord lesions on early components of the median nerve somatosensory evoked potential.
    Emerson RG; Pedley TA
    Neurology; 1986 Jan; 36(1):20-6. PubMed ID: 3941779
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Changes in movement-related cortical potentials in Parkinson's patients before and after treatment with levodopa].
    Feve AP; Bathien N; Rondot P
    Neurophysiol Clin; 1991 May; 21(2):105-19. PubMed ID: 1921938
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Early somatosensory processing during tonic muscle pain in humans: relation to loss of proprioception and motor 'defensive' strategies.
    Rossi S; della Volpe R; Ginanneschi F; Ulivelli M; Bartalini S; Spidalieri R; Rossi A
    Clin Neurophysiol; 2003 Jul; 114(7):1351-8. PubMed ID: 12842734
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Are frontal and parietal somatosensory evoked potentials functionally dissociated by changing stimulus rate?
    Huttunen J
    Int J Neurosci; 1994 Oct; 78(3-4):207-13. PubMed ID: 7883457
    [TBL] [Abstract][Full Text] [Related]  

  • 76. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction.
    Lange KW; Robbins TW; Marsden CD; James M; Owen AM; Paul GM
    Psychopharmacology (Berl); 1992; 107(2-3):394-404. PubMed ID: 1615139
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Early cortical median nerve somatosensory evoked potentials. Prognostic value in anoxic coma.
    Walser H; Mattle H; Keller HM; Janzer R
    Arch Neurol; 1985 Jan; 42(1):32-8. PubMed ID: 3966882
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Microdialysis-HPLC for plasma levodopa and metabolites monitoring in parkinsonian patients.
    Dethy S; Laute MA; Van Blercom N; Damhaut P; Goldman S; Hildebrand J
    Clin Chem; 1997 May; 43(5):740-4. PubMed ID: 9166225
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dissociated changes of frontal and parietal somatosensory evoked potentials in sleep.
    Noguchi Y; Yamada T; Yeh M; Matsubara M; Kokubun Y; Kawada J; Shiraishi G; Kajimoto S
    Neurology; 1995 Jan; 45(1):154-60. PubMed ID: 7824107
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Somatosensory evoked potentials in lacunar syndromes.
    Abbruzzese G; Bino G; Dall'Agata D; Morena M; Primavera A; Favale E
    J Neurol; 1988 May; 235(5):300-3. PubMed ID: 3385447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.